DVA Form 4: Director Reports 369-Share Purchase, 2,525 Trust Shares
Rhea-AI Filing Summary
Wendy L. Schoppert, a director of DaVita Inc. (DVA), reported acquiring 369 shares of DaVita common stock on 08/15/2025 at a reported price of $0. After the transaction she directly owns 369 shares and indirectly owns 2,525 shares through the Wendy L. Schoppert Revocable Trust. The Form 4 was signed by an attorney-in-fact on 08/19/2025. The filing shows a routine insider acquisition by a director and discloses the split between direct and indirect beneficial ownership.
Positive
- Insider acquisition disclosed: Director Wendy L. Schoppert acquired 369 shares, increasing direct ownership.
- Clear beneficial ownership split: Filing specifies 369 shares direct and 2,525 shares indirect via a revocable trust.
- Regulatory compliance: Form 4 filed and signed by attorney-in-fact, satisfying Section 16 reporting requirements.
Negative
- None.
Insights
TL;DR: Routine director purchase disclosed; shows modest insider ownership increase and trust-held shares.
This Form 4 documents a director-level acquisition of 369 shares and confirms indirect holdings via a revocable trust totaling 2,525 shares. From a governance standpoint, the filing fulfils Section 16 reporting obligations and increases the director's direct stake. There is no indication of unusual timing, large scale, or related-party complexity in the disclosed items. The signature by an attorney-in-fact is a standard administrative execution.
TL;DR: Small insider purchase with negligible market impact; compliance disclosure completed.
The reported acquisition of 369 shares at a reported price of $0 is noted on Form 4; the combination of direct and indirect holdings (369 direct, 2,525 indirect) is modest relative to a public company and unlikely to materially affect valuation or control. The report provides transparency on insider ownership but contains no transaction price information that would suggest market-moving intent.
FAQ
What transaction did the DaVita (DVA) Form 4 report for Wendy L. Schoppert?
How many DaVita shares does Wendy L. Schoppert beneficially own after the reported transaction?
Was a purchase price disclosed on the Form 4 for the DVA transaction?
When was the Form 4 for Wendy L. Schoppert signed?
Does the Form 4 indicate insider trading restrictions or a 10b5-1 plan for DVA?